Evidence map›Paper›PMID 38436568›Full record

ArticleZebrafish2024

A Chemically Inducible Muscle Ablation System for the Zebrafish.

Eric Paulissen, Benjamin L Martin

Open access · greenAbstract read
In one paragraph

Article in Zebrafish, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eric PaulissenDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA.
Benjamin L MartinDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA.ORCID 0000-0001-5474-4492
Stony Brook University · US

Funding

MOLECULAR AND CELLULAR BIOLOGY TRAINING PROGRAMT32GM008468 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI NEIMAN, AARON M · 1997 to 2016
$1.9M
Maintenance, germ-layer induction, and patterning of neuromesodermal progenitorsR01GM124282 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI MARTIN, BENJAMIN L · 2018 to 2022
$1.8M
Molecular and Cell Biology of Neuromesodermal ProgenitorsR35GM150290 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Benjamin L Martin · 2023 to 2026
$1.7M
NIGMS NIH HHS R01 GM124282NIGMS NIH HHS R35 GM150290NIGMS NIH HHS T32 GM008468
6 · The paper itself

Abstract

An effective method for tissue-specific ablation in zebrafish is the nitroreductase (NTR)/metronidazole (MTZ) system. Expressing bacterial NTR in the presence of nitroimidazole compounds causes apoptotic cell death, which can be useful for understanding many biological processes. However, this requires tissue-specific expression of the NTR enzyme, and many tissues have yet to be targeted with transgenic lines that express NTR. We generated a transgenic zebrafish line expressing NTR in differentiated skeletal muscle. Treatment of embryos with MTZ caused muscle specific cell ablation. We demonstrate this line can be used to monitor muscle regeneration in whole embryos and in transplanted transgenic cells.

Indexed as

Animals, Genetically ModifiedMetronidazoleMuscle, SkeletalNitroreductasesZebrafishAnimalsRegenerationMetronidazoleNitroreductasesdevelopmentmusclenitroreductaseregenerationzebrafish

Identifiers

PMID38436568
PMCPMC11301710
OpenAlexW4392379106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.